KANK2 and breast cancer: In contrast, KANK2 exhibited negative correlations with inflammation, quiescence, differentiation, metastasis, and invasion in breast cancer (BRCA), as well as with angiogenesis in renal cell carcinoma (RCC) and invasion in ovarian carcinoma (OV) (Figure 7 B-G).